No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs536999772 |
chr2:133734991-133734992 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs569348161 |
chr2:133735037-133735038 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs544065664 |
chr2:133735041-133735042 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs554462242 |
chr2:133735056-133735057 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs35916466 |
chr2:133735073-133735074 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs143459490 |
chr2:133735074-133735075 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs566137039 |
chr2:133735119-133735120 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs183330764 |
chr2:133735166-133735167 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs7589684 |
chr2:133735222-133735223 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
10 |
rs555188573 |
chr2:133735269-133735270 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs540085554 |
chr2:133735300-133735301 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs35634115 |
chr2:133735331-133735332 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs573712877 |
chr2:133735340-133735341 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs537520369 |
chr2:133735363-133735364 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs560624892 |
chr2:133735368-133735369 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs556367845 |
chr2:133735394-133735395 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs199849613 |
chr2:133735402-133735403 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs151027671 |
chr2:133735403-133735404 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs577900575 |
chr2:133735428-133735429 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs372671296 |
chr2:133735440-133735441 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs376902890 |
chr2:133735445-133735446 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs147980565 |
chr2:133735446-133735447 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs141597349 |
chr2:133735481-133735482 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs550540636 |
chr2:133735536-133735537 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs573295711 |
chr2:133735542-133735543 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs188835779 |
chr2:133735592-133735593 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs115311343 |
chr2:133735604-133735605 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs370554889 |
chr2:133735626-133735627 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs193078096 |
chr2:133735671-133735672 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs529436633 |
chr2:133735698-133735699 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs113964152 |
chr2:133735708-133735709 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs577313034 |
chr2:133735733-133735734 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs546281300 |
chr2:133735839-133735840 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs568957753 |
chr2:133735864-133735865 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs562754184 |
chr2:133735935-133735936 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs138453122 |
chr2:133735961-133735962 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs185515488 |
chr2:133735976-133735977 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs370073938 |
chr2:133735999-133736000 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs142977402 |
chr2:133736000-133736001 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs72614500 |
chr2:133736034-133736035 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs548989656 |
chr2:133736075-133736076 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs147020786 |
chr2:133736132-133736133 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs567144732 |
chr2:133736146-133736147 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs187853055 |
chr2:133736169-133736170 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs191154916 |
chr2:133736176-133736177 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs577914977 |
chr2:133736200-133736201 |
Enhancers Weak transcription Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs113658876 |
chr2:133736201-133736202 |
Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs554123592 |
chr2:133736245-133736246 |
Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs146111266 |
chr2:133736252-133736253 |
Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs558585746 |
chr2:133736258-133736259 |
Genic enhancers Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|